It is important that ‘trained health professionals’ counselling men on PSA testing are aware of updates to prostate cancer diagnostic and treatment pathways that may reduce harm, while also informing men of the risks of overdiagnosis and overtreatment. The gene discussed is KLK3; the disease is prostate cancer.